cell danger response glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis Glutathione is critical for NK
Description
Why this trial matters : First oral SERD to succeed in Phase III in early breast cancer Signals a potential new adjuvant standard of care Advances endocrine therapy beyond legacy agents Johnson & Johnson Tecvayli + Darzalex Faspro Shows Unprecedented Phase III Success in Relapsed/Refractory Multiple Myeloma The Phase III MajesTEC-3 trial demonstrated that the combination of Tecvayli (teclistamab) plus Darzalex Faspro (daratumumab SC) significantly improved progression-free survival and overall survival versus standard regimens in patients with relapsed/refractory multiple myeloma as early as second-line, with an ~83% reduction in disease progression or death at almost three years follow-up
That is, the activated ECs modulate inflammatory cells to overexpress scavenger receptors (CD36) and TLRs, essential for vascular oxidative stress (51)
Shi H, Qiao F, Lu W, Huang K, Wen Y, Ye L, et al
The evidence base for the proposed use and its limitations: primarily preclinical, or limited human studies not conducted under Western regulatory standards
Tesamorelin Tesamorelin is a growth hormonereleasing peptide that raises endogenous GH and impacts lipid metabolism and body composition
On the Score List (n = 77), 100% of patients reported brainfog and fatigue and 98.7% reported sensory overload
